The female sex hormone oestrogen as neuroprotectant: Activities at various levels

Novartis Foundation Symposium

Volumn 230, Issue , 2000, Pages 221-238

  Behl, Christian ^a   Moosmann, Bernd ^a   Manthey, Dieter ^a   Heck, Stefanie ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; ESTRADIOL; ESTROGEN; GLUTAMIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; FEMALE; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANTIOXIDANTS; ESTRADIOL; ESTROGENS; FEMALE; GLUTAMATES; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS;

EID: 0033643625     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (50)

1. Aronson MK, Ooi WL, Morgenstern H et al 1990 Women, myocardial infarction, and dementia in the very old. Neurology 40:1102-1106
2. Baeuerle PA, Henkel T 1994 Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179
3. Behl C 1999 Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol 57:301-323
4. Behl C, Holsboer F 1999 The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci 20:441-444
5. Behl C, Davis J, Cole GM, Schubert D 1992 Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Comm 186:944-952
6. Behl C, Davis JB, Lesley R, Schubert D 1994 Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-822
7. Behl C, Widmann M, Trapp T, Holsboer F 1995 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Comm 216:473-482
8. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F 1997a Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138:101-106
9. Behl C, Skutella T, Lezoualc'h F et al 1997b Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535-541
10. Choi DW 1992 Excitotoxic cell death. J Neurobiol 23:1261-1276
11. Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K 1992 Amyloidogenicity of β/A4 and β/A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 267:18210-18217
12. Ebadi M, Srinivasan SK, Baxi MD 1996 Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol 48:1-19
13. Evans DA, Funkenstein HH, Albert MS et al 1989 Prevalence of Alzheimer's disease in a community population of older persons. JAMA 262:2551-2556
14. Glenner GG, Wong CW 1984 Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Comm 120:885-890
15. Green PS, Gordon K, Simpkins JW 1997 Phenolic A ring for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235
16. Gustafsson JÅ 1997 The estrogen receptor beta - getting in on the action? Nat Med 3: 493-494
17. Halliwell B, Gutteridge JMC 1989 Free radicals in biology and medicine, 2nd edn. Oxford University Press, Oxford
18. Hardy J 1997 Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20: 154-159
19. Harris ME, Hensley K, Butterfield A, Leedle RA, Carney JM 1995 Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid (1-40) in cultured hippocampal neurons. Exp Neurol 131:193-202
20. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG 1994 Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51:896-900
21. Hensley K, Carney JM, Mattson MP et al 1994 A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA 91:3270-3274
22. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP 1999 Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96:4686-4691
23. Kelly MJ, Lagrange AH, Wagner EJ, Ronnekleiv OK 1999 Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64:64-75
24. Kuiper GGJM, Shughrue PJ, Merchenthaler I, Gustafsson JÅ 1998 The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 19:253-286
25. Lezoualc'h F, Behl C 1998 Transcription factor NF-κB: friend or foe of neurons? Mol Psychiatry 3:15-20
26. Lipton SA 1997 Janus faces of NF-κB: neurodestruction versus neuroprotection. Nat Med 3: 20-22
27. Luine VN 1994 Steroid hormone influences on spatial memory. Ann NY Acad Sci 743:201-211
28. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K 1985 Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249
29. McEwen BS 1991 Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12:141-147
30. McGeer PL, McGeer EG 1995 The inflammatory response system of brain: implications tor therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21:195-218
31. Moosmann B, Behl C 1999 The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96:8867-8872
32. Moss RL, Gu Q 1999 Estrogen: mechanisms for a rapid action in CA1 hippocampal neurons. Steroids 64:14-21
33. Paganini-Hill A, Henderson VW 1994 Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140:256-261
34. Paul SM Purdy RH 1992 Neuroactive steroids. FASEB J 6:2311-2322
35. Rocca W, Hofman A, Brayne C et al 1991 Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann Neurol 3:381-390
36. Rogers J, Cooper NR, Webster S et al 1992 Complement activation by β-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 89:10016-10020
37. Rosen DR, Siddique T, Patterson D et al 1993 Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62 (erratum: 1993 Nature 364:362)
38. Rupprecht R 1997 The neuropsychophramacological potential of neuroactive steroids. J Psychiatr Res 31:297-314
39. Sapolsky RM 1992 Stress, the aging brain, and the mechanisms of neuron death. MIT Press, Cambridge, MA
40. Shughrue PJ, Lane MV, Merchenthaler I 1999 Biologically active estrogen receptor-beta: evidence from in vivo autoradiographic studies with estrogen receptor alpha-knockout mice. Endocrinology 140:2613-2620
41. Simpkins JW, Singh M, Bishop J 1994 The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging (suppl) 15:S195-S197
42. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM 1999 The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463
43. Smith MA, Sayre LM, Monnier VM, Perry G 1995 Radical AGEing in Alzheimer's disease. Trends Neurosci 18:172-176
44. Tang MX, Jacobs D, Stern Y et al 1996 Effect of oestrogen during menopause on risk and age of onset of Alzheimer's disease. Lancet 348:429-432
45. Toran-Allerand CD 1996 The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci 18:36-48
46. Watters JJ, Dorsa DM 1998 Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J Neurosci 18:6672-6680
47. Woolley CS, McEwen BS 1993 Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 336:293-306
48. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA 1997 Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17:1848-1859
49. Xu H, Gouras GK, Greenfield JP et al 1998 Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 4:447-451
50. Yankner BA 1996 Mechanism of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932